Promising results following the initial experience using Tc-99m-iPSMA led by Dr. Yehia Omar within the Noble Registry.
Prostatic lesions, nodal and bony deposits in a single exam on a gamma camera machine were detected. Therefore, potentially opening up new options for diagnosis for men with prostate cancer in countries that have little or no access to PET/CT or PSMA-PET tracers.
"Our initial experience using Technetium-PSMA seems promising! It shows potential for use in staging cancer prostate patients combined with CT (instead of regular bone scan + CT).
We are able to detect the prostatic lesion, nodal and bony deposits in a single exam on a gamma camera machine.
This new exam may have a big role in areas that don’t have a PET/CT machine or difficult access to PSMA-PET tracers."
More information about the NOBLE Registry >>
Other news & events
- News04.08.2026

Virtual Radiotheranostics Summit: Expanding Access to Targeted Cancer Care Across Africa
Read more - News29.07.2026

TerraPower Isotopes Collaborates with Oncidium Foundation to Donate Actinium-225, Expanding Cancer Treatment Access
Read more - News01.07.2026

Türkiye Introduces Reimbursement for Actinium-225 PSMA Therapy
Read more




